Integra LifeSciences Holdings Corp. (IART)
14.41
+0.06
(+0.42%)
USD |
NASDAQ |
Nov 13, 16:00
14.41
0.00 (0.00%)
After-Hours: 19:59
Integra LifeSciences Holdings Price to Book Value : 1.051 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.047 |
| November 11, 2026 | 1.077 |
| November 10, 2026 | 1.060 |
| November 09, 2026 | 1.048 |
| November 06, 2026 | 0.9789 |
| November 05, 2026 | 1.03 |
| November 04, 2026 | 1.081 |
| November 03, 2026 | 0.9943 |
| November 02, 2026 | 0.9928 |
| October 30, 2026 | 0.9301 |
| October 29, 2026 | 0.9359 |
| October 28, 2026 | 0.8929 |
| October 27, 2026 | 0.8746 |
| October 26, 2026 | 0.8827 |
| October 23, 2026 | 0.8688 |
| October 22, 2026 | 0.8991 |
| October 21, 2026 | 0.8637 |
| October 20, 2026 | 0.9724 |
| October 19, 2026 | 0.9811 |
| October 16, 2026 | 0.9636 |
| October 15, 2026 | 0.987 |
| October 14, 2026 | 0.9611 |
| October 13, 2026 | 1.010 |
| October 12, 2026 | 1.020 |
| October 09, 2026 | 0.9804 |
| Date | Value |
|---|---|
| October 08, 2026 | 0.9782 |
| October 07, 2026 | 0.9483 |
| October 06, 2026 | 0.9716 |
| October 05, 2026 | 0.9695 |
| October 02, 2026 | 0.925 |
| October 01, 2026 | 1.174 |
| September 30, 2026 | 1.188 |
| September 29, 2026 | 1.240 |
| September 28, 2026 | 1.213 |
| September 25, 2026 | 1.202 |
| September 24, 2026 | 1.184 |
| September 23, 2026 | 1.158 |
| September 22, 2026 | 1.194 |
| September 21, 2026 | 1.162 |
| September 18, 2026 | 1.135 |
| September 17, 2026 | 1.126 |
| September 16, 2026 | 1.197 |
| September 15, 2026 | 1.170 |
| September 14, 2026 | 1.171 |
| September 11, 2026 | 1.156 |
| September 10, 2026 | 1.158 |
| September 09, 2026 | 1.211 |
| September 08, 2026 | 1.212 |
| September 04, 2026 | 1.246 |
| September 03, 2026 | 1.226 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Penumbra, Inc. | 7.990 |
| Abbott Laboratories | 3.683 |
| Globus Medical, Inc. | 1.995 |
| AngioDynamics, Inc. | 3.070 |
| Alphatec Holdings, Inc. | -- |
Price to Book Value Related Metrics
| PE Ratio | 87.65 |
| PS Ratio | 0.6775 |
| Price to Free Cash Flow | 15.68 |
| Price | 14.41 |
| Earnings Yield | 1.14% |
| Market Cap | 1.121B |
| Operating PE Ratio | 5.825 |
| Normalized PE Ratio | 12.87 |